Akèy › Maladi atè koronè › Oklahoma › Oklahoma City
Etid klinik pou Maladi atè koronè nan Oklahoma City, OK
6 etid pou Maladi atè koronè ap chèche patisipan nan sit nan ak bò kote Oklahoma City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Ap rekriteFaz 4
- South Oklahoma Heart Research, LLC, Oklahoma City
A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
Ap rekriteFaz 2
- South Oklahoma Heart Research, LLC, Oklahoma City
Prospective Global Registry for the Study of Chronic Total Occlusion Intervention
Ap rekriteEtid obsèvasyon
- Oklahoma City VA Medical Center, Oklahoma City
MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels
Ap rekrite
- University of Oklahoma Health Science Center, Oklahoma City
Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement
Ap rekrite
- Oklahoma Heart, Oklahoma City
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
Ap rekrite
- Oklahoma University Health (OU Health), Oklahoma City
Etid Maladi atè koronè nan lòt vil
- New York City, NY21 etid
- Boston, MA16 etid
- Dallas, TX15 etid
- Atlanta, GA15 etid
- Jacksonville, FL14 etid
- Minneapolis, MN13 etid
- Cleveland, OH13 etid
- Nashville, TN11 etid
- Columbus, OH10 etid
- Durham, NC9 etid
- Philadelphia, PA8 etid
- Los Angeles, CA8 etid
Lòt etid nan Oklahoma City
- Kansè Poumon ki pa ti selil28 etid
- Kansè ovè28 etid
- Kansè Endomèt25 etid
- Kansè kolorektal22 etid
- Kansè pwostat21 etid
- Kansè poumon19 etid
- Kansè nan tete17 etid
- Kansè Metastatik16 etid
- Kansè (tout kalite)14 etid
- Leksemi mieloïd egi14 etid
- Karsinòm selil skuamèz tèt ak kou13 etid
- Kansè vejik11 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.